rTMS and Body Shape Perception

Overview

Anorexia nervosa (AN) is a frequent, potentially life-threatening eating disorder characterized by a resistance to maintaining body weight at or above a minimally normal weight for age and height, an intense fear of weight gain or being "fat" even though underweight, a loss of menstrual periods in girls and women post-puberty and a disturbance in the experience of body weight or shape. Body weight and shape dissatisfaction is linked to the development, maintenance and relapse of AN. Neuroimaging studies have shown that the inferior parietal cortex is involved in body image perception and less activated in patients with AN compared with healthy subjects. Repetitive transcranial magnetic stimulation (rTMS) is used to modulate cortical excitability, and particularly to increase excitability with high-frequency rTMS. The aim of this study was to investigate the effect of "excitatory" high-frequency rTMS over the "hypoactive" inferior parietal cortex of 54 patients with AN. This randomized, double-blind, placebo-controlled study will compare effective rTMS (2000 ten-Hz stimulations per session, applied at 90% of the resting motor threshold, with 10 sessions in two weeks) versus placebo rTMS. Assessments will be performed before rTMS and after the last rTMS session (immediately after, at 15 days and three months). The principal criteria for judgement is a body image satisfaction scale (Boby Shape Questionnaire, BSQ-34). The secondary criteria for judgement are eating behaviour scales (Eating Attitude Test, EAT-40; Bulimia test, BULIT and Eating Disorders Inventory, EDI-2), the Hamilton depression rating scale and Hamilton anxiety rating scale, a quality of life scale (Short-Form Health Survey, SF-36), a body composition analysis using a Dual-energy X-ray absorptiometry and the alpha-MSH autoantibodies levels (biomarker for eating disorders recently described). Inferior parietal cortex rTMS could not only improve body image perception, but also help in the treatment of eating disorders, allowing weight gain with a decreased anxiety and improving patients' quality of life. Also positive results could have direct therapeutic implications with the possibility to complete regular rTMS sessions, or to implant extradural electrodes for chronic parietal cortex stimulation.

Full Title of Study: “Effect of Transcranial Magnetic Stimulation on Disturbance of Body Shape Perception in Patients With Anorexia Nervosa”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
  • Study Primary Completion Date: December 15, 2017

Interventions

  • Procedure: Sham rTMS
    • 120 pulses 0.2Hz
  • Procedure: rTMS
    • 120 pulses 0.2Hz

Arms, Groups and Cohorts

  • Active Comparator: Effective arm
    • Effective coil
  • Placebo Comparator: Placebo arm
    • Placebo coil

Clinical Trial Outcome Measures

Primary Measures

  • BSQ-34 scale (Body Shape Questionnaire)
    • Time Frame: Just after rTMS

Secondary Measures

  • EAT-40 scale (eating attitude test)
    • Time Frame: Before rTMS, just after rTMS, 15 days after rTMS and 3 months after rTMS
  • BULIT scale (bulimia test)
    • Time Frame: Before rTMS, just after rTMS, 15 days after rTMS and 3 months after rTMS
  • EDI-2 scale (eating disorder inventory)
    • Time Frame: Before rTMS, just after rTMS, 15 days after rTMS and 3 months after rTMS
  • Hamilton scale
    • Time Frame: Before rTMS, just after rTMS, 15 days after rTMS and 3 months after rTMSBefore rTMS, just after rTMS, 15 days after rTMS and 3 months after rTMS
  • Quality of Life Scale, MOS 36 Item Short-Form Health Survey or SF-36
    • Time Frame: Before rTMS, just after rTMS, 15 days after rTMS and 3 months after rTMS
  • The body mass index
    • Time Frame: Before rTMS, just after rTMS, 15 days after rTMS and 3 months after rTMS
  • body composition analysis using dual energy X-ray absorptiometry
    • Time Frame: Before rTMS and 3 months after rTMS
  • autoantibodies against alpha-melanocyte stimulating hormone
    • Time Frame: Before rTMS, just after rTMS, 15 days after rTMS and 3 months after rTMS
  • The adverse effects
    • Time Frame: After rTMS
  • Weight
    • Time Frame: Before rTMS, just after rTMS, 15 days after rTMS and 3 months after rTMS
  • BSQ-34 scale (Body Shape Questionnaire)
    • Time Frame: Before rTMS, 15 days after rTMS and 3 months after rTMS

Participating in This Clinical Trial

Inclusion Criteria

  • Female – Age above 18 – Restrictive anorexia nervosa with a disease duration more than one year and less than three years. – Body Mass Index below 16 – Patient receiving or having received optimal treatment for anorexia nervosa – Right-handed – Normal blood ionogramme – Previous stable antidepressor treatment for one month and no expected modification in the three following months – Patients arriving by car with someone else or by public transportation Exclusion Criteria:

  • Pregnancy – Contraindication to transcranial magnetic stimulation i.e. pace-maker, cardiac valve protheses, metallic protheses etc. – History of epileptic seizure – Cerebral lesion of any etiology (post-traumatic, tumoral, vascular etc.) – History of previous rTMS

Gender Eligibility: Female

Minimum Age: 18 Years

Maximum Age: 80 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University Hospital, Rouen
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Nathalie CHASTAN, MD, Principal Investigator, UH Rouen

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.